Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
ISP
Epic Bio to Present Preclinical Data at 28th International Annual Congress of the World Muscle Society
SOUTH SAN FRANCISCO, Calif., Sept. 28, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
CRISPR Therapeutics to Present at the Society for Immunotherapy of Cancer (SITC) 38th Annual Meeting
ZUG, Switzerland and BOSTON, Sept. 27, 2023 (GLOBE NEWSWIRE) — CRISPR Therapeutics (Nasdaq: CRSP), a…
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy
NMD Pharma initiates Phase II trial of NMD670 in Spinal Muscular Atrophy Aarhus, Denmark, 26…
TransCode Therapeutics Announces Pricing of $8 Million Public Offering
BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode Therapeutics, Inc. (Nasdaq: RNAZ), (the “Company”), an…
Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome…
Editas Medicine Reports Inducement Grants to New Chief Commercial and Strategy Officer
CAMBRIDGE, Mass., Sept. 25, 2023 (GLOBE NEWSWIRE) — Editas Medicine, Inc. (Nasdaq: EDIT), a clinical-stage genome…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first…
Editas Medicine Strengthens Executive Leadership Team with Appointment of Caren Deardorf as Chief Commercial and Strategy Officer
Caren Deardorf Editas Medicine, today announced the appointment of Caren Deardorf as the Company’s first…
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Further Supports TTX-MC138 Application in Brain Cancer BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode…
TransCode Therapeutics Announces Positive Pre-Clinical Glioblastoma Results with Lead Therapeutic Candidate, TTX-MC138
Further Supports TTX-MC138 Application in Brain Cancer BOSTON, Sept. 25, 2023 (GLOBE NEWSWIRE) — TransCode…
Metronet Names New CEO, CFO
Company Executes Succession Plan; Prepares for Future Growth EVANSVILLE, Ind.–(BUSINESS WIRE)–Metronet announced today the advancement…
USISPF, ReNew and the Consulate General of India Bring Together Business and Government Leaders to Discuss U.S.- India Climate Partnership
NEW YORK–(BUSINESS WIRE)–$RNW #ClimatePartnership–The US-India Strategic Partnership Forum (USISPF), and ReNew, in partnership with the…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
Epic Bio to Present at Upcoming BMO Biopharma Spotlight Series Event
SOUTH SAN FRANCISCO, Calif., Sept. 19, 2023 (GLOBE NEWSWIRE) — Epic Bio, a biotechnology company…
ADOCIA Announces First Half 2023 Financial Results and Provides a Business Update
As of June 30, 2023 Cash position of €12.1 million (€17.4 million as of December…
Epic Bio Reports Discovery of Exceptionally Durable Gene Activators and Creation of Machine Learning Algorithm to Design New Activators
– Vast high-throughput screening study used to train unique machine learning algorithm to design synthetic…
iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…
iSpecimen Expands Provider Network to Enhance Support for Women’s Health Research
Additional Providers Increase Biospecimen Access for Researchers Focused on Cervical, Uterine and Breast Cancers, as…